RCE recce pharmaceuticals ltd

BobF, don't forget about R435, which is a variant of R327 aimed...

  1. bcr
    5,637 Posts.
    lightbulb Created with Sketch. 132
    BobF, don't forget about R435, which is a variant of R327 aimed specifically at oral administration.
    Source: https://finance.yahoo.com/news/recce-pharmaceuticals-announces-positive-oral-120000992.html

    So, over four years ago, they split off oral dosage into a different development path, so that it will not interrupt development of the flagship product R327, which is aimed at IV administration targeting sepsis in the blood. That is it's primary goal.

    They also created R529, for the same purpose; to not hold up development of R327, yet allow for specifically targeting viral infections.

    Both variants as far as I understand, take a much lower priority to R327 and quite rightly so.
    Last edited by bcr: 09/05/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
32.5¢
Change
0.020(6.56%)
Mkt cap ! $93.72M
Open High Low Value Volume
30.5¢ 33.0¢ 30.0¢ $75.15K 239.0K

Buyers (Bids)

No. Vol. Price($)
1 10934 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.5¢ 14999 1
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.